Germany · Venture startup

Who invested in Qli5 Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Raised 10 months ago

Funding summaryUpdated 26 Oct 2026

$7.2Mraised across 1 round since 2026, from 1 source

Latest round
Venture, $7.2MJan 2026
Investors
1
See who backed them

The rounds

  1. Jan 2026
    Venture$7.2M

    Source recorded

Founders and team

From Qli5 Therapeutics's own website: 2 on the team.

  • Bert KleblCEO and CSO of the LDC
  • Dieter LinkLicensing manager at Max Planck Innovation GmbH

Everyone who backed them

Atinum InvestmentVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Qli5 Therapeutics

Who invested in Qli5 Therapeutics?

Qli5 Therapeutics's investors include Atinum Investment.

How much has Qli5 Therapeutics raised?

Qli5 Therapeutics has raised $7.2M across 1 round since 2026.

When did Qli5 Therapeutics last raise?

Qli5 Therapeutics's most recent round was a Venture of $7.2M in Jan 2026.

What was Qli5 Therapeutics's biggest round?

Its most recent round, $7.2M in Jan 2026, is also its largest on record.

Who backed Qli5 Therapeutics first?

Qli5 Therapeutics's first round on record, in Jan 2026, was backed by Atinum Investment.

What stage is Qli5 Therapeutics at?

Qli5 Therapeutics's latest named round is a Venture, in Jan 2026.

Where is Qli5 Therapeutics based?

Qli5 Therapeutics is based in Germany.

Companies like Qli5 Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.